Coronavirus vaccine: Bharat Biotech asked to submit complete phase 2 data of its vaccine before phase 3 trial

- The vaccine candidate -- 'Covaxin' -- is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)